Glenmark Pharmaceuticals informs about press release

30 Oct 2015 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated , titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1035.00 6.95 (0.68%)
24-May-2024 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.55
Dr. Reddys Lab 5860.25
Cipla 1482.55
Zydus Lifesciences 1072.35
Lupin 1613.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.